1[2]Welliver RC.Therapy for bronchiolitis:help wanted[J]. J Pediatr,1997, 130:170-172.
2[3]Sorrentino M,Powers T,Cargallal G,et al.Effectiveness of palivizumab:evaluation of outcomes from the 1998 to 1999 respiratory cyncytial virus season[J].The Palivizumab Outcomes Study Groupl Pediatr Infect Dis J,2000,19:1068-1071.
3[4]Kajosaari M,Syvanen P,Forars M,et al.Inhaled corticosteroids during and after respiratory syncytial virus-bronchiolitis may decrease subsequent asthma[J].Pediatr Allergy Immunol.2000,11(3):198-202.
4[5]Richter H,Seddon P.Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing[J]. J Pediatr,1998,132(5):849-853.
5[6]Koh YI,Choi IS,Kim WY.BCG infection in allergen-presensitized rats suppresses Th2 immune response and prevents the development of allergic asthmatic reaction[J].J Clin Immunol,2001,21(1):51-59.
7Martin MA.Respiratory syncytial virus infection and asthma[J].Allergol Immunopathol,2001,29:140-146.
8Kim CK,Kim SW,Park CS,et al.Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis[J].J Allergy Clin Immunol,2003,112 (1):64-71.
9Legg JP,Hussain IR,Warner JA,et al.Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis[J].Am J Respir Crit Care Med,2003,168 (6):633-639.
10Annunziato F,Manetti R,Tomasevic I,et al.Expression and release ofLAG-3-encoded protein by human CD4+ T cells are associated with IFN-gamma production[J].FASEB J,1996,10 (7):769-776.
